These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3733374)

  • 41. [Chemosensitivity test for gynecologic malignancies by in vitro colony assay].
    Kano T; Nishida Y; Sakakibara K; Ohta M; Tomoda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2827-36. PubMed ID: 4086909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cooperative evaluation of human tumor chemosensitivity in the soft-agar assay and its clinical correlations.
    Fan D; Morgan LR; Schneider C; Blank H; Fan S
    J Cancer Res Clin Oncol; 1985; 109(1):23-8. PubMed ID: 3882720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Colony assay for clinical application].
    Ichihashi H; Sako T; Akiyama S
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1560-5. PubMed ID: 3927845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes.
    Hills CA; Kelland LR; Abel G; Siracky J; Wilson AP; Harrap KR
    Br J Cancer; 1989 Apr; 59(4):527-34. PubMed ID: 2653399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attempts to optimise colony-forming efficiencies using three different survival assays and a range of human tumour continuous cell lines.
    Hill BT; Whelan RD
    Cell Biol Int Rep; 1983 Aug; 7(8):617-24. PubMed ID: 6352062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model.
    Kotchetkov R; Cinatl J; Blaheta R; Vogel JU; Karaskova J; Squire J; Hernáiz Driever P; Klingebiel T; Cinatl J
    Int J Cancer; 2003 Mar; 104(1):36-43. PubMed ID: 12532417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro evaluation of anticancer drugs with the human tumor stem cell assay.
    Salmon SE; Von Hoff DD
    Semin Oncol; 1981 Dec; 8(4):377-85. PubMed ID: 6275552
    [No Abstract]   [Full Text] [Related]  

  • 48. Chemosensitivity measurements of human tumour cells by soft agar assays are influenced by the culture conditions.
    Endresen L; Tveit KM; Rugstad HE; Pihl A
    Br J Cancer; 1985 Jun; 51(6):843-52. PubMed ID: 4005141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A radiometric method for evaluation of chemotherapy sensitivity: results of screening a panel of human breast cancer cell lines.
    Arteaga CL; Forseth BJ; Clark GM; Von Hoff DD
    Cancer Res; 1987 Dec; 47(23):6248-53. PubMed ID: 3119196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture.
    Tanigawa N; Kern DH; Hikasa Y; Morton DL
    Cancer Res; 1982 Jun; 42(6):2159-64. PubMed ID: 7074595
    [No Abstract]   [Full Text] [Related]  

  • 51. Cultivation of human breast carcinoma in soft agar. Experience with 237 fresh tumour specimens.
    Ottestad L; Tveit KM; Høifødt HK; Nesland JM; Vaage S; Høie J; Lund E; Pihl A
    Br J Cancer; 1988 Jul; 58(1):8-12. PubMed ID: 3048354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A rapid in vitro screening system for the identification and evaluation of anticancer drugs.
    Kao JW; Collins JL
    Cancer Invest; 1989; 7(4):303-11. PubMed ID: 2590857
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo.
    Palmberg E; Johnsen JI; Paulsson J; Gleissman H; Wickström M; Edgren M; Ostman A; Kogner P; Lindskog M
    Int J Cancer; 2009 Mar; 124(5):1227-34. PubMed ID: 19058199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro growth and drug sensitivity of tumor colony-forming units from human tumor xenografts.
    Taetle R; Koessler AK; Howel SB
    Cancer Res; 1981 May; 41(5):1856-60. PubMed ID: 7214353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anticancer drug activity in human bladder tumor cell lines.
    Niell HB; Webster KC; Smith EE
    Cancer; 1985 Sep; 56(5):1039-44. PubMed ID: 4016694
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemosensitivity of human head and neck cancer xenografts in the clonogenic assay and in nude mice.
    Boerrigter GH; Heinerman EC; Braakhuis BJ; Snow GB
    Br J Cancer; 1986 Jul; 54(1):53-9. PubMed ID: 3730256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor regression and curability of preclinical neuroblastoma models by PEGylated SN38 (EZN-2208), a novel topoisomerase I inhibitor.
    Pastorino F; Loi M; Sapra P; Becherini P; Cilli M; Emionite L; Ribatti D; Greenberger LM; Horak ID; Ponzoni M
    Clin Cancer Res; 2010 Oct; 16(19):4809-21. PubMed ID: 20702613
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Results of in vitro chemosensitivity assays: human tumor clonogenic and scintillation assay].
    Tanigawa N; Morimoto H; Akita T; Inoue H; Tanaka T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1176-84. PubMed ID: 3729439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multidrug resistance modulation in rhabdomyosarcoma and neuroblastoma cell lines.
    Cowie FJ; Pritchard-Jones K; Renshaw J; Pinkerton CR
    Int J Oncol; 1998 May; 12(5):1143-9. PubMed ID: 9538141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.